中枢神经系统参与心脏粉症:重新定义心脑轴
Domenico Mario Giamundo1, Giuliano Cassataro2,3, Stefano Ministrini4,5
1Department of Systems Medicine, "Tor Vergata" University, Rome, Italy.
European journal of clinical investigation
|September 23, 2025
概括
心脏粉症是一种涉及心脏中粉素积聚的疾病,可以影响中枢神经系统. 研究探讨了心脏氨基粉症和大脑健康之间的联系,表明因素的复杂相互作用.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 系统性疾病 系统性疾病
背景情况:
- 氨基粉症涉及错误折叠的蛋白质的细胞外积累.
- 由于心肌干扰,心脏粉症会损害心脏功能.
- 心脏粉症可以影响中枢神经系统 (CNS).
研究的目的:
- 审查目前关于中枢神经系统参与心脏粉症的证据.
- 在心脏粉症中探索连接心脏和大脑的病理生理机制.
主要方法:
- 现有文献的叙述性审查.
- 关于心脏粉症和中枢神经系统影响的证据综合.
主要成果:
- 中枢神经系统参与心脏 Amyloidosis 是多因素的.
- 机制包括直接的粉样蛋白沉积,脑血管变化和心脏功能障碍.
- 心脏粉症和认知衰退之间的关系是复杂的,并未完全理解.
结论:
- 认知障碍越来越多地被认为是心脏粉症.
- 需要进一步的研究来了解中枢神经系统的参与.
- 多学科的方法对于管理患者至关重要.
相关概念视频
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Cardiomyopathy IV: Restrictive Cardiomyopathy
461
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
461
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480


